Board of Directors

Wenche Rolfsen
Wenche Rolfsen
Chairman of the Board since 2017, Board member since 2016. Chairman of the Remuneration Committee.

Born
1952

Education
Pharmacist, Doctor of Pharmacy (pharma-cognosy), Adjunct Professor at Uppsala University, Sweden

Other assignments
Chairman of InDex Pharmaceuticals Holding AB. Board member of Swedish Match AB and InDex Diagnostics AB; CEO and Board member of Rolfsen Consulting AB. Partner in Serendipity Partners.

Experience and prior assignments
Head of pharmacology at Pharmacia & Upjohn; VP clinical trials Quintiles Europe, CEO of Quintiles Scandinavia. Chairman of Aprea Therapeutics AB, Denator AB and Aprea Personal AB. Board member of SOBI AB, Recipharm AB, Smartfish AB, Moberg Pharma AB, TFS Trial Form Support Internatio-nal AB, Apotek Produktion & Laboratorier AB and Industrifonden.

Total holdings*
47,175 Class B shares

Independent in relation to BioArctic, its senior management and major shareholders.

Ivar Verner
Ivar Verner
Deputy chairman since 2017, Board member since 2010. Chairman of the Audit Committee.

Born
1947

Education
Master of Business Administration, Stockholm School of Economics, Sweden.

Other assignments
Chairman of Erlandsons Brygga AB, Centrum Fastigheter i Norrtalje AB, Tegner & Son AB and Valsattra Exploaterings AB. Board member of Sehlhall Fastigheter AB.

Experience and prior assignments
Chairman of Rejlers AB, Welcome Hotel i Sverige AB, Constrera AB and Grant Thornton Sweden AB. Board member of Forex Bank AB and Svenska Vardfastigheter AB.

Total holdings*
99,770 Class B shares, privately and through Förvaltningsaktiebolaget Kanalen AB

Independent in relation to BioArctic, its senior management and major shareholders.

Hans Ekelund
Hans Ekelund
Board member since 2014. Member of the Audit Committee and the Remuneration Committee.

Born
1948

Education
Master of Business Administration, Stockholm School of Economics, Sweden.

Other assignments
Chairman of Connect Öst (non-profit organization) and board member of Ekarna Invest AB.

Experience and prior assignments
Former CFO of Ratos and several assignments as Board member.

Total holdings*
69,770 Class B shares, privately and through Ekarna Invest AB

Independent in relation to BioArctic, its senior management and major shareholders.

Håkan Englund
Board member since 2020

Born
1952

Education
Various courses in economics and chemistry from Uppsala University, Sweden. Courses in polymer technology at Royal Institute of Technology in Stockholm, Sweden.

Other assignments
Chairman of the Board of SecureAppbox AB. Board member of Antrad Medical AB, Immuneed AB and Chundsell Medicals AB. Owner and CEO of JDS Invest AB. Company involved in business consulting and private placements in both private and public companies.

Experience and prior assignments
Various management positions, including commercial leadership roles, at Pharmacia Biotech AB and Phadia AB with over 30 years of experience in the industry. Previous board director at Apotekssamariten AB, Olink AB, Sensidose AB and Arocell AB.

Total holdings*
0 shares

Independent in relation to BioArctic, its senior management and major shareholders.

Pär Gellerfors
Pär Gellerfors
Board member since 2003. Former CEO. Founder of BioArctic together with Lars Lannfelt.

Born
1947

Education
Bachelor degree in chemistry; PhD in chemistry; Associate Professor of Biochemistry. All at Stockholm University, Sweden.

Other assignments
CEO and Board member of Swenora Biotech AB. Board member of Ackelsta AB, LPB Sweden AB and Sigrid Therapeutics AB.

Experience and prior assignments
CEO and board member of SpineMedical Sverige AB and SpineMedical AB. Board member of LPB Sweden Holding AB.

Total holdings*
5,759,988 Class A shares through Ackelsta AB
15,086,301 Class B shares through Ackelsta AB

Dependent in relation to BioArctic, its senior management and in relation to major shareholders

Lars Lannfelt
Lars Lannfelt
Board member since 2003. Chairman of the Board, 2003–2017. Chairman of the Research Committee. Founder of BioArctic with Pär Gellerfors.

Born
1949

Education
Medical degree (specialist in psychiatry) and doctoral thesis at Karolinska Institutet, Stockholm, Sweden; Associate Professor of Neurogenetics at Karolinska Institutet, speci-alist in geriatrics.

Other assignments
Board member of Demban AB and LPB Sweden AB.

Experience and prior assignments
Professor of Geriatrics at Uppsala University; Senior Professor at Uppsala University and member of the Royal Swedish Academy of Sciences. Founder of BioArctic in 2003, Chairman of the Board and a number of assignments and roles in the company.

Total holdings* 
8,639,998 Class A shares through Demban AB
22,628,052 Class B shares through Demban AB

Dependent in relation to BioArctic, its senior management and in relation to major shareholders

Mikael Smedeby
Mikael Smedeby
Board member since 2018.

Born
1968

Education 
Master of Laws, Uppsala University, Sweden.

Other assignments
Lawyer and partner Advokatfirman Lindahl, Chairman of the Board of Coeli Holding AB and Sallengruppen AB (including subsidiaries). Board member of Smedeby Förvaltning AB.

Experience and prior assignments
General Counsel, Structures Freemont SA. Active as a lawyer since 1994. Member of the Swedish Bar Association. Executive positions at Advokatfirman Lindahl, including Managing Partner and Chairman of the Board. Member of the Board of Directors of BioArctic, 2014–2017. Special experience in corporate law, mergers and acquisitions, financing and licensing.

Total holdings*
37,270 Class B shares

Mikael Smedeby is independent in relation to the major shareholders of the company. Because BioArctic purchases services from the law firm Lindahl, where Mikael Smedeby is a partner, he is not regarded as independent in relation to the company or its executive management

Eugen Steiner
Eugen Steiner
Board member since 2017. Member of the Audit Committee and the Remuneration Committee.

Born
1954

Education
Medical doctor, Ph.D. in clinical pharmacology at Karolinska Institutet, Stockholm, Sweden.

Other assignments
Chairman of the Board of Spago Nanomedical AB and Empros Pharma AB. Board member of Apotek Produktion & Laboratorier AB, Inbox Capital AB, Karolinska Institutet Holding AB, Stiftelsen Forska!Sverige and Stockholm School of Entrepreneurship. Partner in HealthCap.

Experience and prior assignments
CEO or acting Chairman of the Board in several life science companies in Sweden, Norway and the US for more than 30 years, most recently as CEO of Glionova AB. CEO and Chairman of the Board of NVC Holdings AB.

Total holdings*
67,270 Class B shares

Independent in relation to BioArctic, its senior management and major shareholders

* Pertains to own holdings, related party holdings, holdings in companies and in capital insurance